Latest RARE reports update at 2024-05-18: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q3
  1. Home
  2. Stock quotes
  3. Ultragenyx Pharmaceutical
  4. Financial Ratios
Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical RARE
$ 41.22 -0.82%
mail-toReport an Error

Ultragenyx Pharmaceutical Financial Ratios 2011-2024 | RARE

Annual Financial Ratios Ultragenyx Pharmaceutical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -5.8 -3.5 -12.6 -45.1 -6.0 -11.0 -6.5 -10.9 -14.2 -27.9 - - -

P/S

 8.1 6.7 16.2 31.1 23.3 42.0 753.8 20180.4 - - - - -

EPS

 -8.2 -10.1 -6.7 -3.1 -7.1 -1.7 -7.1 -6.2 -4.0 -2.2 -14.9 -14.2 -

EV (Enterprise Value)

 4.53 B 3.51 B 5.99 B 8.31 B 2.46 B 2.16 B 1.98 B 2.59 B 2 B 1.66 B 2.11 M -82.2 M 1.49 M

EBITDA per Share

 -7.39 -9.02 -5.44 -5.22 -7.35 -7.07 -7.61 -6.18 -3.98 -1.95 - - -

EV/EBITDA

 -16.2 -24.3 -6.2 -6.6 -6.9 -10.3 -13.5 -29.4 - - -

PEG

 -1.08 -0.46 13.28 -4.87 -0.17 -0.28 0.53 0.19 0.19 -0.33 - - -

P/B

 12.8 7.0 6.2 7.3 3.7 3.6 5.1 5.7 3.9 9.0 - - -

P/CF

 -7.4 -6.4 -16.8 -63.7 -7.0 -7.4 -7.8 -15.7 -18.6 -35.7 - - -

ROE %

 -220.26 -200.69 -49.21 -16.16 -61.60 -32.45 -78.79 -51.87 -27.42 -32.34 - - -

ROA %

 -40.69 -45.77 -29.82 -10.60 -35.47 -27.46 -61.57 -45.48 -26.02 -30.21 - - -

ROCE %

 -206.67 -184.09 -41.38 -21.03 -41.09 -57.59 -78.37 -51.63 -27.79 -30.62 - - -

Current Ratio

 1.2 1.3 2.5 2.9 2.4 6.5 4.6 6.7 16.1 15.5 - - -

DSO

 47.8 34.6 26.8 37.7 80.2 63.5 361.4 - - - - - -

DIO

 - - - - - 1245.7 138152.5 - - - - - -

DPO

 - - - - - 3369.9 2600625.0 - - - - - -

Operating Cycle

 47.8 34.6 26.8 37.7 80.2 1309.1 138513.9 - - - - - -

Cash Conversion Cycle

 47.8 34.6 26.8 37.7 80.2 -2060.8 -2462111.1 - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Ultragenyx Pharmaceutical

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -2.03 - -2.23 -2.25 -2.33 - -3.5 -2.26 -2.19 - -1.08 -1.81 -2.03 -0.37 -1.13 0.42 -2.05 -1.62 -1.96 -1.72 -1.82 -1.73 -1.74 -1.06 0.63 -1.89 -1.87 -1.72 -1.63 -1.75 -1.64 -1.46 -1.35 -1.42 -1.03 -0.83 -0.63 -0.52 -0.5 -0.45 -0.85 -4.98 -3.48 -3.32 -2.84 - - - - - - - -

EBITDA per Share

 -1.86 - - - -2.12 - -3.21 -2.02 -1.91 - -1.32 -1.22 -1.54 - -0.68 -0.95 -1.98 - -1.93 -1.88 -1.82 - -1.45 -1.66 -1.87 - -1.89 -1.8 -1.64 - -1.61 -1.46 -1.36 - -1.02 -0.83 -0.63 - -0.49 -0.45 -0.47 - -2.05 -2.29 -1.91 - - - - - - - -

ROE %

 -1252.36 -701.64 -753.92 -302.80 -202.26 -94.73 -102.55 -58.09 -47.36 -33.32 -35.40 -37.92 -21.68 -28.31 -40.58 -45.79 -61.52 -52.89 -52.97 -51.77 -48.33 -32.45 -39.34 -45.67 -56.02 -78.79 -72.52 -65.55 -58.55 -51.87 -47.23 -40.93 -34.52 -27.42 -26.07 -27.25 -28.99 -32.34 -8.16 11.67 30.50 46.87 31.75 20.48 9.00 - - - - - - - -

ROA %

 -51.04 -36.94 -52.08 -54.33 -54.12 -38.13 -43.04 -32.81 -28.93 -21.53 -22.90 -23.41 -13.39 -14.52 -21.41 -25.94 -36.60 -35.47 -39.41 -41.59 -40.19 -27.46 -31.91 -35.92 -43.45 -61.57 -58.10 -53.96 -49.64 -45.48 -42.16 -37.17 -31.96 -26.02 -24.61 -25.60 -27.14 -30.21 -40.73 -46.85 -54.39 -58.79 -39.82 -25.69 -11.29 - - - - - - - -

ROCE %

 - - -48.01 -96.01 -116.89 -86.04 -95.66 -57.28 -44.91 -28.24 -35.79 -33.73 -34.28 -36.43 -52.66 -61.33 -65.99 -41.14 -55.86 -54.35 -56.22 -46.15 -67.98 -75.09 -79.96 -60.53 -74.41 -66.46 -58.25 -37.44 -44.96 -38.60 -32.03 -17.24 -25.81 -26.85 -28.56 -21.54 -11.17 7.77 26.18 30.41 30.41 20.04 9.02 - - - - - - - -

Current Ratio

 1.1 1.2 1.0 1.1 1.2 1.3 1.4 2.1 2.4 2.5 2.7 2.8 2.9 2.9 2.1 2.1 2.0 2.4 2.4 2.4 2.4 6.5 6.5 6.5 6.5 4.6 4.6 4.6 4.6 8.1 8.1 8.1 8.1 19.6 19.6 19.6 19.6 15.2 15.2 15.2 15.2 6.2 6.2 6.2 6.2 - - - - - - - -

DSO

 - - - - - - - - 32.4 - 28.0 26.1 22.1 23.0 25.9 34.1 70.3 84.2 116.2 124.1 114.5 71.5 98.8 90.9 76.5 195.5 2383.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - 1375.4 1878.6 - 2361.5 4572.2 1586.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - 1533.3 2538.2 - 4102.9 7943.9 4291.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - 32.4 - 28.0 26.1 22.1 23.0 25.9 34.1 70.3 84.2 116.2 1499.5 1993.0 71.5 2460.3 4663.1 1662.7 195.5 2383.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - 32.4 - 28.0 26.1 22.1 23.0 25.9 34.1 70.3 84.2 116.2 -33.7 -545.2 71.5 -1642.6 -3280.9 -2628.3 195.5 2383.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency